A massive number of patients are launching compensation claims against manufacturers of the heartburn medication Zantac. Complaints against the drug center around possible links to cancer, leading to a wave of lawsuits. The US government has also phased out the sale of Zantac, heightening concerns about its safety. Attorneys predict that these law